Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA
Precipio Inc (PRPO) reported record Q2 2026 revenue of $7M, up 22% YoY. Adjusted EBITDA turned positive at $400K, driven by revenue growth and lower stock-based compensation. The company added new distributor reps and expects pipeline conversions to boost growth. CEO Ilan Danieli highlighted the 'flywheel' model's competitive advantage and the market potential of the AML product.
How this was made

The 30-second read
Why it matters
The company achieved record revenue and turned EBITDA positive, suggesting operational leverage and cash generation.
Market read
Micro‑cap earnings with positive surprise may drive short‑term price movement.
What to watch
High trading volume and algorithmic activity could increase volatility regardless of fundamentals.
Background
Precipio Inc (PRPO) held its Q2 2026 earnings call, presenting its first quarterly results for the period.
Ticker impact
Precipio reported record Q2 revenue of $7M, positive adjusted EBITDA of $0.4M and $700K operating cash flow, the first earnings disclosure for the quarter.
Potential modest price rise on post‑earnings momentum.
Micro‑cap earnings surprise can move the stock, but limited liquidity caps magnitude.
Market effects
Highlights growth potential in the diagnostic pathology market.
U.S. micro‑cap healthcare segment may see increased investor interest.
Limited to niche diagnostic sector; no broad market effect.
Counterpoint
Given the small scale, the earnings beat may be priced in quickly, limiting upside.
Key entities
- ExecutiveIlan Danieli
CEO of Precipio who provided the earnings commentary.

